Dunbar Geoffrey C 4

4 · TARGACEPT INC · Filed Dec 21, 2010

Form 4

Period: 2010-12-17

VP, Clin. Dev. & Reg. Affairs

Transactions

Exercise/Conversion
Common Stock
2010-12-17$1.75/sh+2,100$3,675→ 3,253 total
Sale
Common Stock
2010-12-17$26.08/sh−2,100$54,765→ 1,153 total
Sale
Common Stock
2010-12-20$26.02/sh−8,882$231,120→ 1,153 total
Exercise/Conversion
Stock Option (Right to Buy)
2010-12-17−2,100→ 2,100 total
Exercise: $1.75Exp: 2013-01-30→ Common Stock (2,100 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2010-12-20−6,782→ 0 total
Exercise: $1.75Exp: 2013-10-30→ Common Stock (6,782 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2010-12-20−2,100→ 0 total
Exercise: $1.75Exp: 2013-01-30→ Common Stock (2,100 underlying)
Exercise/Conversion
Common Stock
2010-12-20$1.75/sh+8,882$15,544→ 10,035 total

Footnotes (6)

[F1]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.22, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.17, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F3]This option vested in installments and became vested and exercisable in full upon completion of the issuer's initial public offering.
[F4]Does not include 10,749 shares subject to the unexercised portion of this option for which the exercise price is $5.10 per share.
[F5]This option vested in installments and became vested and exercisable in full on September 30, 2007.
[F6]Does not include 29,638 shares subject to the unexercised portion of this option for which the exercise price is $5.10 per share.

Documents

1 file